z-logo
open-access-imgOpen Access
<i>In vitro</i> maturation with letrozole priming: Can it be a solution for patients with cancerophobia? A pilot study
Author(s) -
Şafak Hatırnaz,
Ebru Hatırnaz,
Alper Başbuğ,
Mine Kanat Pektaş,
Onur Erol,
Michael H. Dahan,
Seang Lin Tan
Publication year - 2020
Publication title -
türk jinekoloji ve obstetrik derneði dergisi/türk jinekoloji ve obstetrik derneği dergisi
Language(s) - English
Resource type - Journals
eISSN - 1307-7007
pISSN - 1307-699X
DOI - 10.4274/tjod.galenos.2020.79446
Subject(s) - letrozole , antral follicle , medicine , in vitro fertilisation , ovarian hyperstimulation syndrome , controlled ovarian hyperstimulation , germinal vesicle , infertility , ovarian reserve , andrology , priming (agriculture) , follicle stimulating hormone , endocrinology , gynecology , aromatase , hormone , biology , pregnancy , luteinizing hormone , oocyte , breast cancer , embryo , cancer , botany , germination , genetics , microbiology and biotechnology
To investigate whether letrozole priming could be used efficiently in patients undergoing in vitro maturation (IVM) as compared with follicle-stimulating hormone (FSH) priming.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here